Established in 2023 through the merger of G42 Healthcare and Mubadala Health, M42 is a global healthcare company based in Abu Dhabi driving a new era of precision medicine and AI-enabled care. The group combines advanced clinical services, genomics research, and digital-health capabilities across a network of over 450 facilities in 24 countries. By integrating data, technology, and compassionate expertise, M42 delivers patient-centric solutions and redefines global healthcare excellence.
Established Since
2023
Annual Revenue
Over $1 billion
Employees
2,000
Business Attribute
Agent/ Distributor
Healthcare Provider & Services
Consulting Service
Business Nature
Medical Devices & Hospital Equipment
Company Highlights
1
Advanced Clinical Network
The group manages over 450 facilities across 24 countries, including the renowned Cleveland Clinic Abu Dhabi and HealthPoint Hospital.
2
Leader in Precision Health
M42 integrates world-class medical expertise with cutting-edge genomics, data science, and digital health technologies to deliver personalized care solutions.
3
AI & Data-Driven Innovation
Through its HealthTech platforms, M42 transforms diagnostics, disease management, and patient experience using real-time analytics and predictive AI.
Market Presence
Headquartered in Abu Dhabi, M42 operates across the UAE, MENA region, and globally, connecting healthcare systems, clinics, and research centers to deliver scalable precision-health solutions.
Brands in Charge for Distribution
Cleveland Clinic Abu Dhabi. HealthPoint Hospital. Imperial College London Diabetes Centre. Amana Healthcare. Mubadala Health Network.
Strategic Focus Areas
M42 focuses on genomics, digital health transformation, AI-powered diagnostics, and international collaborations that enhance precision medicine and sustainable healthcare delivery.